Stem Cell Week

Research findings from J.L.M. Ferrara et al update understanding of lymphocytic leukemia

Stem Cell Week Library Library Home This article was published in Stem Cell Week, which you can subscribe to online.

"New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. Injune 2007 the Blood and Marrow Transplant Clinical Trials Network convened a State of the Science Symposium of more than 200 participants in Ann Arbor to identify the most compelling clinical research opportunities in the field," wrote J.L.M. Ferrara and colleagues.

The researchers concluded: "This report summarizes the symposium's discussions and identifies eleven high priority clinical trials that the network plans to pursue over the course of the next several years."

Ferrara and colleagues published the results of their research in Biology of Blood and Marrow Transplantation (Blood and marrow transplant clinical trials network state of the science symposium 2007. Biology of Blood and Marrow Transplantation, 2007;13(11):1268-1285).

For additional information, contact J.L.M. Ferrara, 1500 E Med Center Dr., 6303 Cancer Center, Ann Arbor, MI, USA.

The publisher of the journal Biology of Blood and Marrow Transplantation can be contacted at: Elsevier Science Inc., 360 Park Avenue South, New York, NY 10010-1710, USA.

Keywords: United States, Ann Arbor, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Cell Transplantation, Chronic Lymphocytic Leukemia, Clinical Trial Research, Crohn Disease, Gastroenterology, Gastrointestinal, Graft-Versus-Host Disease, Hematology, Hematopoietic, Lymphohistiocytosis, Oncology, Stem Cell Research, T-Cell Lymphoma.

This article was prepared by Stem Cell Week editors from staff and other reports. Copyright 2008, Stem Cell Week via NewsRx.com.